B. Krust

发表

Inhibition of HIV infection by the cytokine midkine.

S. Nisole, J. Briand, A. Hovanessian, 2001, Virology.

The V3 loop-mimicking pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits HIV infection in primary macrophage cultures.

S. Nisole, S. Muller, J. Briand, 1999, AIDS research and human retroviruses.

Specific and irreversible cyclopeptide inhibitors of dipeptidyl peptidase IV activity of the T-cell activation antigen CD26.

J. Blanco, E. Jacotot, A. Hovanessian, 1998, Journal of medicinal chemistry.

The Anti-HIV Pentameric Pseudopeptide HB-19 Binds the C-terminal End of Nucleolin and Prevents Anchorage of Virus Particles in the Plasma Membrane of Target Cells*

M. Prevost, S. Nisole, A. Bianco, 2002, The Journal of Biological Chemistry.

Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.

J. Blanco, E. Jacotot, A. Hovanessian, 1997, Advances in experimental medicine and biology.

Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.

J. Blanco, E. Jacotot, A. Hovanessian, 1996, European journal of biochemistry.

Neutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells

J. Blanco, R. Franco, A. Hovanessian, 1997, Journal of virology.

The caveolin-1 binding domain of HIV-1 glycoprotein gp41 is an efficient B cell epitope vaccine candidate against virus infection.

S. Muller, J. Briand, C. Desgranges, 2004, Immunity.

Monoclonal antibodies to an interferon-induced Mr 68,000 protein and their use for the detection of double-stranded RNA-dependent protein kinase in human cells.

A. Laurent, A. Hovanessian, J. Galabru, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques

J. Estaquier, R. Le Grand, A. Hovanessian, 2018, Journal of Virology.

The cell-surface-expressed nucleolin is associated with the actin cytoskeleton.

S. Nisole, E. Perret, F. Puvion-Dutilleul, 2000, Experimental cell research.

Surface Expressed Nucleolin Is Constantly Induced in Tumor Cells to Mediate Calcium-Dependent Ligand Internalization

A. Hovanessian, B. Krust, J. Svab, 2010, PloS one.

The Anti-HIV Cytokine Midkine Binds the Cell Surface-expressed Nucleolin as a Low Affinity Receptor*

S. Nisole, J. Briand, E. Said, 2002, The Journal of Biological Chemistry.

Identification of V3 Loop-binding Proteins as Potential Receptors Implicated in the Binding of HIV Particles to CD4+Cells*

E. Dam, J. Blanco, S. Muller, 1998, The Journal of Biological Chemistry.

Phosphorylation of the alpha-chain of fibrinogen by a platelet kinase activity enhanced by interferon.

A. Hovanessian, J. Galabru, B. Krust, 1983, Biochemical and biophysical research communications.

CD26 as a positive regulator of HIV envelope-glycoprotein induced apoptosis in CD4+ T cells.

J. Blanco, E. Jacotot, Y. Rivière, 1997, Advances in experimental medicine and biology.

HIV-2 EHO isolate has a divergent envelope gene and induces single cell killing by apoptosis.

L. Montagnier, M. Rey-Cuillé, A. Hovanessian, 1994, Virology.

CD4 T Follicular Helper Cells and HIV Infection: Friends or Enemies?

G. Andreani, J. Estaquier, R. Silvestre, 2017, Frontiers in immunology.

Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells.

M. Kieny, C. Dauguet, S. Muller, 1993, AIDS research and human retroviruses.

The anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolin

E. Jacotot, J. Briand, C. Rougeot, 2001, Proceedings of the National Academy of Sciences of the United States of America.

T cell activation antigen, CD26, as a cofactor for entry of HIV in CD4+ cells.

E. Jacotot, A. Hovanessian, C. Callebaut, 1993, Science.

Pseudopeptide TASP Inhibitors of HIV Entry Bind Specifically to a 95-kDa Cell Surface Protein*

E. Jacotot, J. Briand, G. Guichard, 1997, The Journal of Biological Chemistry.

HIV‐1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin‐1 binding motif of viral glycoprotein gp41

S. Muller, J. Briand, M. Rey-Cuillé, 2006, The Journal of pharmacy and pharmacology.

The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.

R. Le Grand, F. Martinon, A. Hovanessian, 2009, Molecular immunology.

Membrane-expressed HIV envelope glycoprotein heterodimer is a powerful inducer of cell death in uninfected CD4+ target cells.

E. Coccia, A. Hovanessian, B. Krust, 1995, Research in virology.

Inhibition of entry of HIV into cells by poly(A).poly(U).

A. Hovanessian, C. Callebaut, B. Krust, 1993, AIDS research and human retroviruses.

Early Loss of Splenic Tfh Cells in SIV-Infected Rhesus Macaques

G. Andreani, J. Estaquier, R. Silvestre, 2015, PLoS pathogens.

Dipeptidyl‐peptidase IV‐β

J. Blanco, E. Jacotot, A. Hovanessian, 1998 .

Characterisation of the interferon-mediated protein kinase by polyclonal antibodies.

A. Laurent, A. Hovanessian, B. Krust, 1984, Biochemical and biophysical research communications.

The level of CD26 determines the rate of HIV entry in a CD4+ T-cell line.

J. Blanco, E. Jacotot, A. Hovanessian, 1997, Advances in experimental medicine and biology.

The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells.

J. Briand, D. Legrand, J. Mazurier, 2009, Experimental cell research.

Characterization of human immunodeficiency virus type 2 envelope glycoproteins: dimerization of the glycoprotein precursor during processing

L. Montagnier, A. Laurent, A. Hovanessian, 1989, Journal of virology.

Characterization of an HIV-2-related virus with a smaller sized extracellular envelope glycoprotein.

L. Montagnier, D. Guétard, A. Laurent, 1989, Virology.

Characterization of monoclonal antibody specific for human alpha interferon.

J. Gruest, L. Montagnier, A. Laurent, 1982, Hybridoma.

HIV-1 envelope glycoproteins-mediated apoptosis is regulated by CD4 dependent and independent mechanisms

J. Blanco, E. Jacotot, A. Hovanessian, 2004, Apoptosis.

The cytopathic effect of HIV is associated with apoptosis.

L. Montagnier, S. Muller, Y. Rivière, 1991, Virology.

Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice

Masashi Kato, J. Briand, A. Prévost-Blondel, 2010, BMC Cancer.

Increased rate of HIV-1 entry and its cytopathic effect in CD4+/CXCR4+ T cells expressing relatively high levels of CD26.

J. Blanco, E. Jacotot, A. Hovanessian, 1998, Experimental cell research.

Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type

A. Hovanessian, Diala El Khoury, B. Krust, 2011, BMC Cancer.

Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed Nucleolin

P. Albanese, J. Briand, G. Guichard, 2008, PloS one.

Identification and antigenicity of the major envelope glycoprotein of lymphadenopathy-associated virus.

J. Chermann, F. Barré-Sinoussi, F. Rey, 1985, Virology.

The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes.

M. Rey-Cuillé, A. Hovanessian, B. Krust, 2009, Vaccine.

The Anti-HIV Pseudopeptide HB-19 Forms a Complex with the Cell-surface-expressed Nucleolin Independent of Heparan Sulfate Proteoglycans*

S. Nisole, J. Briand, G. Guichard, 1999, The Journal of Biological Chemistry.

The HB-19 pseudopeptide 5[Kpsi(CH2N)PR]-TASP inhibits attachment of T lymophocyte- and macrophage-tropic HIV to permissive cells.

E. Dam, S. Nisole, S. Muller, 2000, AIDS research and human retroviruses.

HIV envelope glycoprotein-induced cell killing by apoptosis is enhanced with increased expression of CD26 in CD4+ T cells.

J. Blanco, E. Jacotot, Y. Rivière, 1996, Virology.

Anchorage of HIV on permissive cells leads to coaggregation of viral particles with surface nucleolin at membrane raft microdomains.

S. Nisole, A. Hovanessian, B. Krust, 2002, Experimental cell research.

Antiviral action of polyadenylic-polyuridylic acid against HIV in cell cultures.

L. Montagnier, A. Hovanessian, B. Krust, 1992, AIDS research and human retroviruses.

Transmembrane envelope glycoproteins of human immunodeficiency virus type 2 and simian immunodeficiency virus SIV-mac exist as homodimers

L. Montagnier, A. Laurent, A. Hovanessian, 1990, Journal of virology.

Pleiotrophin inhibits HIV infection by binding the cell surface‐expressed nucleolin

J. Courty, J. Delbe, E. Said, 2005, The FEBS journal.

Efficient synthesis and comparative studies of the arginine and Nω,Nω‐dimethylarginine forms of the human nucleolin glycine/arginine rich domain

S. Pongor, G. Esposito, S. Zahariev, 2005 .

Bromodeoxyuridine‐induced reversion of transformed characteristics in BHK21 cells: Changes at the plasma membrane level

L. Montagnier, G. Torpier, B. Krust, 1979, Journal of cellular physiology.

Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment.

E. Coccia, A. Hovanessian, B. Krust, 1994, The Journal of biological chemistry.

Interferon-mediated protein kinase activity in different fractions of mouse L-929 cells.

A. Hovanessian, J. Galabru, B. Krust, 1984, Journal of interferon research.

Further characterization of the protein kinase activity mediated by interferon in mouse and human cells.

A. Hovanessian, J. Galabru, B. Krust, 1984, The Journal of biological chemistry.

Assay of interferon-mediated protein kinase activity from plasma and tissue extracts.

Y. Rivière, A. Hovanessian, B. Krust, 1983, Analytical biochemistry.

p67K kinase in different tissues and plasma of control and interferon-treated mice.

Y. Rivière, A. Hovanessian, B. Krust, 1982, Virology.

Cell surface expression of several species of human immunodeficiency virus type 1 major core protein

L. Montagnier, A. Laurent, A. Hovanessian, 1989, Journal of virology.

Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin.

A. Hovanessian, Diala El Khoury, B. Krust, 2011, Biochimie.

Specific binding of adenosine deaminase but not HIV-1 transactivator protein Tat to human CD26.

J. Blanco, E. Jacotot, A. Hovanessian, 1996, Experimental cell research.

Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.

J. Blanco, E. Jacotot, A. Hovanessian, 1998, European journal of biochemistry.

Characterization of a monoclonal antibody specific for the HIV-1 precursor glycoprotein.

L. Montagnier, A. Le Guern, A. Laurent, 1988, AIDS.

Production of a non-functional nef protein in human immunodeficiency virus type 1-infected CEM cells.

B. Guy, A. Régnault, M. Kieny, 1990, Journal of General Virology.

[Apoptosis and AIDS, a question of integration?].

J. Estaquier, R. Silvestre, V. Rodrigues, 2013, Medecine sciences : M/S.

Inhibition of HIV infection by pseudopeptides blocking viral envelope glycoprotein-mediated membrane fusion and cell death.

J. Blanco, S. Muller, E. Jacotot, 1996, Virology.

Replication of Subgenomic Hepatitis C Virus Rnas in a Hepatoma Cell Line

J. Silver, R. Bartenschlager, S. Shinton, 1999 .